FDA Grants Class II Status For Power Morcellator Containment Systems

The agency will require 510(k) clearance for the devices, which can be used to isolate tissue removed from the uterus during morcellation. However, labeling will need to state that the systems have not been proven to reduce the risk of cancer.

More from Regulation

More from Policy & Regulation